Financing type:  underwritten prospectus offering

Gross proceeds:  $106.25-million

Offering:  10,625,000 listed shares

Offering price:   $10.00 per listed share

Overallotment option:  The underwriters may purchase a maximum of 1.3 million listed shares for overallotment purposes. As of May 6, 2026, a total of 625,000 listed shares have been issued thereunder. All information presented herein includes such exercise. The company has been advised no further overallotment shares will be exercised.

Public disclosure:  refer to the prospectus supplement dated April 29, 2026, and the company's news release(s) dated April 27, 2026, and May 6, 2026